Facile and rapid one-step radiosynthesis of [18F]BAY94-9172 with a new precursor

Nuclear Medicine and Biology

Volumn 38, Issue 1, 2011, Pages 121-127

  Wang, Hongliang ^a   Shi, Huixian ^a   Yu, Haiyan ^a   Jiang, Shende ^a   Tang, Ganghua ^b  

^a TIANJIN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; BAY94 9172; Florbetaben; PET; Radiosynthesis

Indexed keywords

FLORBETABEN;

ARTICLE; AUTOMATION; CONTROLLED STUDY; DRUG PURIFICATION; DRUG PURITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY; STRUCTURE ANALYSIS;

ANILINE COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORINE RADIOISOTOPES; KINETICS; MESYLATES; RADIOCHEMISTRY; STILBENES;

EID: 78650967860     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2010.06.009     Document Type: Article

References (21)

1. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
2. Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol 2004, 3:519-527.
3. Johnson K.A., Jones K., Holman B.L., Becker J.A., Spiers P.A., Satlin A., et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998, 50:1563-1571.
4. Nordberg A. Amyloid imaging in Alzheimer's disease. Neuropsychologia 2008, 46:1636-1641.
5. Styren S.D., Hamilton L., Styren G.C., Klunk W.E. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J Histochem Cytochem 2000, 48:1223-1232.
6. Agdeppa E., Kepe V., Liu J., Flores-Torres M., Satyamurthy N., Petric A., et al. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer's disease. J Neurosci 2001, 21:1-5.
7. Klunk W.E., Wang Y., Huang G., Debnath M.L., Holt D.P., Mathis C.A. Uncharged thioflavin-T derivatives bind to amyloidbeta protein with high affinity and readily enter the brain. Life Sci 2001, 69:1471-1484.
8. Kung H.F., Lee C.W., Zhuang Z.P., Kung M.P., Hou C., Plossl K. Novel stilbenes as probes for amyloid plaques. J Am Chem Soc 2001, 123:12740-12741.
9. Ryu E.K., Choe Y.S., Lee K.H., Choi Y., Kim B.T. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for β-amyloid plaque imaging. J Med Chem 2006, 49:6111-6119.
10. Shimadzu H., Suemoto T., Suzuki M., Shiomitsu T., Okamura N., Kudo Y., et al. A novel probe for imaging amyloid-β: synthesis of F-18 labelled BF-108, an acridine orange analog. J Label Compd Radiopharm 2003, 4:765-772.
11. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004, 55:306-319.
12. Verhoeff Nicolaas P.L.G., Wilson A.A., Takeshita S., Trop L., Hussey D., Singh K., et al. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]-SB-13 PET. Am J Geriatr Psych 2004, 12:584-595.
13. Mathis C., Lopresti B., Mason N., Price J., Flatt N., Bi W., et al. Comparison of the amyloid imaging agents [F-18]3′-F-PIB and [C-11]PIB in Alzheimer's disease and control subjects. J Nucl Med 2007, 48:56.
14. Rowe C.C., Ackerman U., Browne W., Mulligan R., Pike K.L., O'Keefe G., et al. Imaging of amyloid in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol 2008, 7:129-135.
15. Skovronsky D., Coleman R.E., Frey K., Garg P., Ichise M., Lowe V., et al. Results of multi-center multi-ligand clinical trials with five 18F-labeled amyloid-imaging agents in Alzheimer's disease patients and healthy elderly controls. J Nucl Med 2008, 49:34.
16. Zhang W., Oya S., Kung M.P., Hou C., Maier D.L., Kung H.F. F-18 polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain. Nucl Med Biol 2005, 32(8):799-809.
17. O'Keefe G.J., Saunder T.H., Ng S., Ackerman U., Tochon-Danguy H.J., Chan J.G., et al. Radiation dosimetry of β-amyloid tracers 11C-PiB and 18F-BAY94-9172. J Nucl Med 2009, 50:309-315.
18. Huynh T.H., Mante M.L., Mikkelsen K., Lindhardt A.T., Nielsen N.C., Otzen D., et al. A versatile approach to β-amyloid fibril-binding compounds exploiting the Shirakawa/Hayashi protocol for trans-alkene synthesis. Org Lett 2009, 11:999-1002.
19. Ono M., Wilson A., Nobrega J., Westaway D., Verhoeff P., Zhuang Z.P., et al. 11C-Labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease. Nucl Med Biol 2003, 30:565-571.
20. Sun X., Hai L., Wu Y., Hu H.Y., Zhang Z.R. Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD). J Drug Target 2005, 13:121-128.
21. Qu W.C., Kung M.P., Hou C., Benedum T.E., Kung H.F. Novel styrylpyridines as probes for SPECT imaging of amyloid plaques. J Med Chem 2007, 50:2157-2165.